Vistagen Therapeutics, Inc. (VTGN)
0.6781
+0.02
(+2.26%)
USD |
NASDAQ |
Dec 30, 16:00
0.6742
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Market Cap: 26.78M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 415.45M |
| XOMA Royalty Corp. | 324.19M |
| Omeros Corp. | 1.202B |
| GeoVax Labs, Inc. | 5.106M |
| Daré Bioscience, Inc. | 28.01M |
Market Cap Related Metrics
| PS Ratio | 23.80 |
| PEG Ratio | -0.0174 |
| Price to Book Value | 0.4037 |
| Price | 0.6781 |
| Earnings Yield | -279.9% |
| PEGY Ratio | -0.0174 |